Report Summary
Eternity Insights has published a new study on Global Digital Therapeutics Market focusing on key segments By Product Type (Software, Device), By Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), Others), By Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)), and by region. This deep dive research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Digital Therapeutics Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Digital Therapeutics Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Digital Therapeutics Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Digital Therapeutics Market Segmentation:
Digital Therapeutics Market, By Product Type
Digital Therapeutics Market, By Application
- Diabetes
- Obesity
- Cardiovascular Disease (CVD)
- Central Nervous System (CNS) Disease
- Respiratory Disease
- Smoking Cessation
- Gastrointestinal Disorder (GID)
- Others
Digital Therapeutics Market, By Sales Channel
- Business-to-Business (B2B)
- Employer
- Healthcare Provider
- Others
- Business-to-Consumer (B2C)
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Digital Therapeutics market in terms of demand generation. The Digital Therapeutics market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Digital Therapeutics market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Digital Therapeutics Market Taxonomy:
To learn more about this report
Global Digital Therapeutics Market Competitive Landscape
The global Digital Therapeutics market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Proteus Digital Health, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Livongo Health
- Noom Inc.
- Ginger.Io, Inc.
- Propeller Health
- 2morrow Inc.
- Canary Health Inc.
- Mango Health Inc.
- Other Players of Specific Interest can be added based on the requirement
Market Segmentation
Report Attributes |
Details |
The market size value in 2021 |
USD XX.XX Million |
CAGR (2021 - 2028) |
XX.XX % |
The Revenue forecast in 2028 |
USD XX.XX Million |
Base year for estimation |
2021 |
Historical data |
2018-2019 |
Forecast period |
2022-2028 |
Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
By Product Type Outlook |
Software, Device |
By Application Outlook |
Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), Others |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled |
Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Livongo Health, Noom Inc., Ginger.Io, Inc., Propeller Health, 2morrow Inc., Canary Health Inc., Mango Health Inc. |
Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Digital Therapeutics Market Overview
1.1 Digital Therapeutics Product Overview
1.2 Digital Therapeutics Market Segment by Type
1.2.1 B2C
1.2.2 B2B
1.3 Global Digital Therapeutics Market Size by Type
1.3.1 Global Digital Therapeutics Sales and Growth by Type
1.3.2 Global Digital Therapeutics Sales and Market Share by Type (2017-2020)
1.3.3 Global Digital Therapeutics Revenue and Market Share by Type (2017-2020)
1.3.4 Global Digital Therapeutics Price by Type (2017-2020)
2 Global Digital Therapeutics Market Competition by Company
2.1 Global Digital Therapeutics Sales and Market Share by Company (2017-2020)
2.2 Global Digital Therapeutics Revenue and Share by Company (2017-2020)
2.3 Global Digital Therapeutics Price by Company (2017-2020)
2.4 Global Top Players Digital Therapeutics Manufacturing Base Distribution, Sales Area, Product Types
2.5 Digital Therapeutics Market Competitive Situation and Trends
2.5.1 Digital Therapeutics Market Concentration Rate
2.5.2 Global Digital Therapeutics Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Digital Therapeutics Company Profiles and Sales Data
3.1 Proteus Digital Health, Inc.
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Digital Therapeutics Product Category, Application and Specification
3.1.3 Proteus Digital Health, Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Omada Health, Inc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Digital Therapeutics Product Category, Application and Specification
3.2.3 Omada Health, Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Welldoc, Inc.
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Digital Therapeutics Product Category, Application and Specification
3.3.3 Welldoc, Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Livongo Health
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Digital Therapeutics Product Category, Application and Specification
3.4.3 Livongo Health Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Noom Inc.
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Digital Therapeutics Product Category, Application and Specification
3.5.3 Noom Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Ginger.Io, Inc.
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Digital Therapeutics Product Category, Application and Specification
3.6.3 Ginger.Io, Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Propeller Health
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Digital Therapeutics Product Category, Application and Specification
3.7.3 Propeller Health Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 2morrow Inc.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Digital Therapeutics Product Category, Application and Specification
3.8.3 2morrow Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Canary Health Inc.
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Digital Therapeutics Product Category, Application and Specification
3.9.3 Canary Health Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 Mango Health Inc.
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Digital Therapeutics Product Category, Application and Specification
3.10.3 Mango Health Inc. Digital Therapeutics Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
4 Digital Therapeutics Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Digital Therapeutics Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Digital Therapeutics Sales and Revenue by Regions
4.2.1 Global Digital Therapeutics Sales and Market Share by Regions (2017-2020)
4.2.2 Global Digital Therapeutics Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Digital Therapeutics Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Digital Therapeutics Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Digital Therapeutics Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Digital Therapeutics Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Digital Therapeutics Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Digital Therapeutics Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Digital Therapeutics Application/End Users
5.1 Digital Therapeutics Segment by Application
5.1.1 Preventive
5.1.2 Treatment/Care
5.2 Global Digital Therapeutics Product Segment by Application
5.2.1 Global Digital Therapeutics Sales by Application
5.2.2 Global Digital Therapeutics Sales and Market Share by Application (2017-2020)
6 Global Digital Therapeutics Market Forecast
6.1 Global Digital Therapeutics Sales, Revenue Forecast (2021-2027)
6.1.1 Global Digital Therapeutics Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Digital Therapeutics Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Digital Therapeutics Forecast by Regions
6.2.1 North America Digital Therapeutics Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Digital Therapeutics Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Digital Therapeutics Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Digital Therapeutics Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Digital Therapeutics Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Digital Therapeutics Forecast by Type
6.3.1 Global Digital Therapeutics Sales and Revenue Forecast by Type (2021-2027)
6.3.2 B2C Gowth Forecast
6.3.3 B2B Gowth Forecast
6.4 Digital Therapeutics Forecast by Application
6.4.1 Global Digital Therapeutics Sales Forecast by Application (2021-2027)
6.4.2 Global Digital Therapeutics Forecast in Preventive
6.4.3 Global Digital Therapeutics Forecast in Treatment/Care
7 Digital Therapeutics Upstream Raw Materials
7.1 Digital Therapeutics Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Digital Therapeutics Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer